English
简体中文
Total: £ 56.28
Published Date: 2026-03-16 | Pages: 123 | Tables: 125 | Pharma & Healthcare
The global Self-replicating mRNA Vaccines market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Self-replicating mRNA Vaccines competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
A more common name for self-replicating mRNA is self-amplifying RNA (saRNA). The important difference compared to ordinary mRNA is that it can use its own RNA sequence as a template to replicate itself. Usually mRNA encodes the protein that needs to be expressed, and the ribosomes in the cell are used to complete the translation and protein production. In addition to expressing the target protein, saRNA also carries a sequence that can express RNA polymerase (RNA-dependent RNA polymerase, RdRP). After this RNA polymerase is produced, it can use saRNA as a template to produce more copies of saRNA.
The North American market for Self-replicating mRNA Vaccines is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Self-replicating mRNA Vaccines is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Self-replicating mRNA Vaccines include Chimeron Bio, Ziphius Vaccines, Aldevron, VaxEquity, Precision Nanosystems, Replicate Bioscience, Elixirgen Therapeutics, Immorna, CSL, Arcturus Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Self-replicating mRNA Vaccines market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Self-replicating mRNA Vaccines. The Self-replicating mRNA Vaccines market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Self-replicating mRNA Vaccines market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Self-replicating mRNA Vaccines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Chimeron Bio
Ziphius Vaccines
Aldevron
VaxEquity
Precision Nanosystems
Replicate Bioscience
Elixirgen Therapeutics
Immorna
CSL
Arcturus Therapeutics
BioNTech
GSK
Gritstone Bio
Segment by Type
Preventive Medicine
Medicine
by Application
Infectious Disease
Cancer
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Self-replicating mRNA Vaccines manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Self-replicating mRNA Vaccines sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Self-replicating mRNA Vaccines Market Overview
1.1 Product Definition
1.2 Self-replicating mRNA Vaccines by Type
1.2.1 Global Self-replicating mRNA Vaccines Market Value by Type: 2025 vs 2032
1.2.2 Preventive Medicine
1.2.3 Medicine
1.3 Self-replicating mRNA Vaccines by Application
1.3.1 Global Self-replicating mRNA Vaccines Market Value by Application: 2025 vs 2032
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Others
1.4 Global Self-replicating mRNA Vaccines Market Size Estimates and Forecasts
1.4.1 Global Self-replicating mRNA Vaccines Revenue 2021–2032
1.4.2 Global Self-replicating mRNA Vaccines Sales 2021–2032
1.4.3 Global Self-replicating mRNA Vaccines Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Self-replicating mRNA Vaccines Market Competition by Manufacturers
2.1 Global Self-replicating mRNA Vaccines Sales Market Share by Manufacturers (2021–2026)
2.2 Global Self-replicating mRNA Vaccines Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Self-replicating mRNA Vaccines Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Self-replicating mRNA Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Self-replicating mRNA Vaccines, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Self-replicating mRNA Vaccines, Product Types and Applications
2.7 Global Key Manufacturers of Self-replicating mRNA Vaccines, Date of Entry into the Industry
2.8 Global Self-replicating mRNA Vaccines Market Competitive Situation and Trends
2.8.1 Global Self-replicating mRNA Vaccines Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Self-replicating mRNA Vaccines Players Market Share by Revenue
2.8.3 Global Self-replicating mRNA Vaccines Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Self-replicating mRNA Vaccines Market Scenario by Region
3.1 Global Self-replicating mRNA Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Self-replicating mRNA Vaccines Sales by Region: 2021–2032
3.2.1 Global Self-replicating mRNA Vaccines Sales by Region: 2021–2026
3.2.2 Global Self-replicating mRNA Vaccines Sales by Region: 2027–2032
3.3 Global Self-replicating mRNA Vaccines Revenue by Region: 2021–2032
3.3.1 Global Self-replicating mRNA Vaccines Revenue by Region: 2021–2026
3.3.2 Global Self-replicating mRNA Vaccines Revenue by Region: 2027–2032
3.4 North America Self-replicating mRNA Vaccines Market Facts & Figures by Country
3.4.1 North America Self-replicating mRNA Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Self-replicating mRNA Vaccines Sales by Country (2021–2032)
3.4.3 North America Self-replicating mRNA Vaccines Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Self-replicating mRNA Vaccines Market Facts & Figures by Country
3.5.1 Europe Self-replicating mRNA Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Self-replicating mRNA Vaccines Sales by Country (2021–2032)
3.5.3 Europe Self-replicating mRNA Vaccines Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Self-replicating mRNA Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Self-replicating mRNA Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Self-replicating mRNA Vaccines Sales by Region (2021–2032)
3.6.3 Asia Pacific Self-replicating mRNA Vaccines Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Self-replicating mRNA Vaccines Market Facts & Figures by Country
3.7.1 Latin America Self-replicating mRNA Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Self-replicating mRNA Vaccines Sales by Country (2021–2032)
3.7.3 Latin America Self-replicating mRNA Vaccines Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Self-replicating mRNA Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Self-replicating mRNA Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Self-replicating mRNA Vaccines Sales by Country (2021–2032)
3.8.3 Middle East and Africa Self-replicating mRNA Vaccines Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Self-replicating mRNA Vaccines Sales by Type (2021–2032)
4.1.1 Global Self-replicating mRNA Vaccines Sales by Type (2021–2026)
4.1.2 Global Self-replicating mRNA Vaccines Sales by Type (2027–2032)
4.1.3 Global Self-replicating mRNA Vaccines Sales Market Share by Type (2021–2032)
4.2 Global Self-replicating mRNA Vaccines Revenue by Type (2021–2032)
4.2.1 Global Self-replicating mRNA Vaccines Revenue by Type (2021–2026)
4.2.2 Global Self-replicating mRNA Vaccines Revenue by Type (2027–2032)
4.2.3 Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2021–2032)
4.3 Global Self-replicating mRNA Vaccines Price by Type (2021–2032)
5 Segment by Application
5.1 Global Self-replicating mRNA Vaccines Sales by Application (2021–2032)
5.1.1 Global Self-replicating mRNA Vaccines Sales by Application (2021–2026)
5.1.2 Global Self-replicating mRNA Vaccines Sales by Application (2027–2032)
5.1.3 Global Self-replicating mRNA Vaccines Sales Market Share by Application (2021–2032)
5.2 Global Self-replicating mRNA Vaccines Revenue by Application (2021–2032)
5.2.1 Global Self-replicating mRNA Vaccines Revenue by Application (2021–2026)
5.2.2 Global Self-replicating mRNA Vaccines Revenue by Application (2027–2032)
5.2.3 Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2021–2032)
5.3 Global Self-replicating mRNA Vaccines Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Chimeron Bio
6.1.1 Chimeron Bio Company Information
6.1.2 Chimeron Bio Description and Business Overview
6.1.3 Chimeron Bio Self-replicating mRNA Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Chimeron Bio Self-replicating mRNA Vaccines Product Portfolio
6.1.5 Chimeron Bio Recent Developments/Updates
6.2 Ziphius Vaccines
6.2.1 Ziphius Vaccines Company Information
6.2.2 Ziphius Vaccines Description and Business Overview
6.2.3 Ziphius Vaccines Self-replicating mRNA Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Ziphius Vaccines Self-replicating mRNA Vaccines Product Portfolio
6.2.5 Ziphius Vaccines Recent Developments/Updates
6.3 Aldevron
6.3.1 Aldevron Company Information
6.3.2 Aldevron Description and Business Overview
6.3.3 Aldevron Self-replicating mRNA Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Aldevron Self-replicating mRNA Vaccines Product Portfolio
6.3.5 Aldevron Recent Developments/Updates
6.4 VaxEquity
6.4.1 VaxEquity Company Information
6.4.2 VaxEquity Description and Business Overview
6.4.3 VaxEquity Self-replicating mRNA Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 VaxEquity Self-replicating mRNA Vaccines Product Portfolio
6.4.5 VaxEquity Recent Developments/Updates
6.5 Precision Nanosystems
6.5.1 Precision Nanosystems Company Information
6.5.2 Precision Nanosystems Description and Business Overview
6.5.3 Precision Nanosystems Self-replicating mRNA Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Precision Nanosystems Self-replicating mRNA Vaccines Product Portfolio
6.5.5 Precision Nanosystems Recent Developments/Updates
6.6 Replicate Bioscience
6.6.1 Replicate Bioscience Company Information
6.6.2 Replicate Bioscience Description and Business Overview
6.6.3 Replicate Bioscience Self-replicating mRNA Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Replicate Bioscience Self-replicating mRNA Vaccines Product Portfolio
6.6.5 Replicate Bioscience Recent Developments/Updates
6.7 Elixirgen Therapeutics
6.7.1 Elixirgen Therapeutics Company Information
6.7.2 Elixirgen Therapeutics Description and Business Overview
6.7.3 Elixirgen Therapeutics Self-replicating mRNA Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Elixirgen Therapeutics Self-replicating mRNA Vaccines Product Portfolio
6.7.5 Elixirgen Therapeutics Recent Developments/Updates
6.8 Immorna
6.8.1 Immorna Company Information
6.8.2 Immorna Description and Business Overview
6.8.3 Immorna Self-replicating mRNA Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Immorna Self-replicating mRNA Vaccines Product Portfolio
6.8.5 Immorna Recent Developments/Updates
6.9 CSL
6.9.1 CSL Company Information
6.9.2 CSL Description and Business Overview
6.9.3 CSL Self-replicating mRNA Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 CSL Self-replicating mRNA Vaccines Product Portfolio
6.9.5 CSL Recent Developments/Updates
6.10 Arcturus Therapeutics
6.10.1 Arcturus Therapeutics Company Information
6.10.2 Arcturus Therapeutics Description and Business Overview
6.10.3 Arcturus Therapeutics Self-replicating mRNA Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Arcturus Therapeutics Self-replicating mRNA Vaccines Product Portfolio
6.10.5 Arcturus Therapeutics Recent Developments/Updates
6.11 BioNTech
6.11.1 BioNTech Company Information
6.11.2 BioNTech Description and Business Overview
6.11.3 BioNTech Self-replicating mRNA Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 BioNTech Self-replicating mRNA Vaccines Product Portfolio
6.11.5 BioNTech Recent Developments/Updates
6.12 GSK
6.12.1 GSK Company Information
6.12.2 GSK Description and Business Overview
6.12.3 GSK Self-replicating mRNA Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 GSK Self-replicating mRNA Vaccines Product Portfolio
6.12.5 GSK Recent Developments/Updates
6.13 Gritstone Bio
6.13.1 Gritstone Bio Company Information
6.13.2 Gritstone Bio Description and Business Overview
6.13.3 Gritstone Bio Self-replicating mRNA Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Gritstone Bio Self-replicating mRNA Vaccines Product Portfolio
6.13.5 Gritstone Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Self-replicating mRNA Vaccines Industry Chain Analysis
7.2 Self-replicating mRNA Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Self-replicating mRNA Vaccines Production Mode & Process Analysis
7.4 Self-replicating mRNA Vaccines Sales and Marketing
7.4.1 Self-replicating mRNA Vaccines Sales Channels
7.4.2 Self-replicating mRNA Vaccines Distributors
7.5 Self-replicating mRNA Vaccines Customer Analysis
8 Self-replicating mRNA Vaccines Market Dynamics
8.1 Self-replicating mRNA Vaccines Industry Trends
8.2 Self-replicating mRNA Vaccines Market Drivers
8.3 Self-replicating mRNA Vaccines Market Challenges
8.4 Self-replicating mRNA Vaccines Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Self-replicating mRNA Vaccines Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Self-replicating mRNA Vaccines Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Self-replicating mRNA Vaccines Market Competitive Situation by Manufacturers in 2025
Table 4. Global Self-replicating mRNA Vaccines Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Self-replicating mRNA Vaccines Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Self-replicating mRNA Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Self-replicating mRNA Vaccines Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Self-replicating mRNA Vaccines Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Self-replicating mRNA Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Self-replicating mRNA Vaccines, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Self-replicating mRNA Vaccines, Product Types and Applications
Table 12. Global Key Manufacturers of Self-replicating mRNA Vaccines, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Self-replicating mRNA Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Self-replicating mRNA Vaccines Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Self-replicating mRNA Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Self-replicating mRNA Vaccines Sales by Region (K Units), 2021–2026
Table 18. Global Self-replicating mRNA Vaccines Sales Market Share by Region (2021–2026)
Table 19. Global Self-replicating mRNA Vaccines Sales by Region (K Units), 2027–2032
Table 20. Global Self-replicating mRNA Vaccines Sales Market Share by Region (2027–2032)
Table 21. Global Self-replicating mRNA Vaccines Revenue by Region (US$ Million), 2021–2026
Table 22. Global Self-replicating mRNA Vaccines Revenue Market Share by Region (2021–2026)
Table 23. Global Self-replicating mRNA Vaccines Revenue by Region (US$ Million), 2027–2032
Table 24. Global Self-replicating mRNA Vaccines Revenue Market Share by Region (2027–2032)
Table 25. North America Self-replicating mRNA Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Self-replicating mRNA Vaccines Sales by Country (K Units), 2021–2026
Table 27. North America Self-replicating mRNA Vaccines Sales by Country (K Units), 2027–2032
Table 28. North America Self-replicating mRNA Vaccines Revenue by Country (US$ Million), 2021–2026
Table 29. North America Self-replicating mRNA Vaccines Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Self-replicating mRNA Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Self-replicating mRNA Vaccines Sales by Country (K Units), 2021–2026
Table 32. Europe Self-replicating mRNA Vaccines Sales by Country (K Units), 2027–2032
Table 33. Europe Self-replicating mRNA Vaccines Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Self-replicating mRNA Vaccines Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Self-replicating mRNA Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Self-replicating mRNA Vaccines Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Self-replicating mRNA Vaccines Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Self-replicating mRNA Vaccines Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Self-replicating mRNA Vaccines Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Self-replicating mRNA Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Self-replicating mRNA Vaccines Sales by Country (K Units), 2021–2026
Table 42. Latin America Self-replicating mRNA Vaccines Sales by Country (K Units), 2027–2032
Table 43. Latin America Self-replicating mRNA Vaccines Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Self-replicating mRNA Vaccines Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Self-replicating mRNA Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Self-replicating mRNA Vaccines Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Self-replicating mRNA Vaccines Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Self-replicating mRNA Vaccines Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Self-replicating mRNA Vaccines Revenue by Country (US$ Million), 2027–2032
Table 50. Global Self-replicating mRNA Vaccines Sales (K Units) by Type (2021–2026)
Table 51. Global Self-replicating mRNA Vaccines Sales (K Units) by Type (2027–2032)
Table 52. Global Self-replicating mRNA Vaccines Sales Market Share by Type (2021–2026)
Table 53. Global Self-replicating mRNA Vaccines Sales Market Share by Type (2027–2032)
Table 54. Global Self-replicating mRNA Vaccines Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Self-replicating mRNA Vaccines Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2021–2026)
Table 57. Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2027–2032)
Table 58. Global Self-replicating mRNA Vaccines Price (US$/Unit) by Type (2021–2026)
Table 59. Global Self-replicating mRNA Vaccines Price (US$/Unit) by Type (2027–2032)
Table 60. Global Self-replicating mRNA Vaccines Sales (K Units) by Application (2021–2026)
Table 61. Global Self-replicating mRNA Vaccines Sales (K Units) by Application (2027–2032)
Table 62. Global Self-replicating mRNA Vaccines Sales Market Share by Application (2021–2026)
Table 63. Global Self-replicating mRNA Vaccines Sales Market Share by Application (2027–2032)
Table 64. Global Self-replicating mRNA Vaccines Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Self-replicating mRNA Vaccines Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2021–2026)
Table 67. Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2027–2032)
Table 68. Global Self-replicating mRNA Vaccines Price (US$/Unit) by Application (2021–2026)
Table 69. Global Self-replicating mRNA Vaccines Price (US$/Unit) by Application (2027–2032)
Table 70. Chimeron Bio Company Information
Table 71. Chimeron Bio Description and Business Overview
Table 72. Chimeron Bio Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Chimeron Bio Self-replicating mRNA Vaccines Product
Table 74. Chimeron Bio Recent Developments/Updates
Table 75. Ziphius Vaccines Company Information
Table 76. Ziphius Vaccines Description and Business Overview
Table 77. Ziphius Vaccines Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Ziphius Vaccines Self-replicating mRNA Vaccines Product
Table 79. Ziphius Vaccines Recent Developments/Updates
Table 80. Aldevron Company Information
Table 81. Aldevron Description and Business Overview
Table 82. Aldevron Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Aldevron Self-replicating mRNA Vaccines Product
Table 84. Aldevron Recent Developments/Updates
Table 85. VaxEquity Company Information
Table 86. VaxEquity Description and Business Overview
Table 87. VaxEquity Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. VaxEquity Self-replicating mRNA Vaccines Product
Table 89. VaxEquity Recent Developments/Updates
Table 90. Precision Nanosystems Company Information
Table 91. Precision Nanosystems Description and Business Overview
Table 92. Precision Nanosystems Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Precision Nanosystems Self-replicating mRNA Vaccines Product
Table 94. Precision Nanosystems Recent Developments/Updates
Table 95. Replicate Bioscience Company Information
Table 96. Replicate Bioscience Description and Business Overview
Table 97. Replicate Bioscience Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Replicate Bioscience Self-replicating mRNA Vaccines Product
Table 99. Replicate Bioscience Recent Developments/Updates
Table 100. Elixirgen Therapeutics Company Information
Table 101. Elixirgen Therapeutics Description and Business Overview
Table 102. Elixirgen Therapeutics Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Elixirgen Therapeutics Self-replicating mRNA Vaccines Product
Table 104. Elixirgen Therapeutics Recent Developments/Updates
Table 105. Immorna Company Information
Table 106. Immorna Description and Business Overview
Table 107. Immorna Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Immorna Self-replicating mRNA Vaccines Product
Table 109. Immorna Recent Developments/Updates
Table 110. CSL Company Information
Table 111. CSL Description and Business Overview
Table 112. CSL Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. CSL Self-replicating mRNA Vaccines Product
Table 114. CSL Recent Developments/Updates
Table 115. Arcturus Therapeutics Company Information
Table 116. Arcturus Therapeutics Description and Business Overview
Table 117. Arcturus Therapeutics Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Arcturus Therapeutics Self-replicating mRNA Vaccines Product
Table 119. Arcturus Therapeutics Recent Developments/Updates
Table 120. BioNTech Company Information
Table 121. BioNTech Description and Business Overview
Table 122. BioNTech Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. BioNTech Self-replicating mRNA Vaccines Product
Table 124. BioNTech Recent Developments/Updates
Table 125. GSK Company Information
Table 126. GSK Description and Business Overview
Table 127. GSK Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. GSK Self-replicating mRNA Vaccines Product
Table 129. GSK Recent Developments/Updates
Table 130. Gritstone Bio Company Information
Table 131. Gritstone Bio Description and Business Overview
Table 132. Gritstone Bio Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Gritstone Bio Self-replicating mRNA Vaccines Product
Table 134. Gritstone Bio Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Self-replicating mRNA Vaccines Distributors List
Table 138. Self-replicating mRNA Vaccines Customers List
Table 139. Self-replicating mRNA Vaccines Market Trends
Table 140. Self-replicating mRNA Vaccines Market Drivers
Table 141. Self-replicating mRNA Vaccines Market Challenges
Table 142. Self-replicating mRNA Vaccines Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Self-replicating mRNA Vaccines
Figure 2. Global Self-replicating mRNA Vaccines Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Self-replicating mRNA Vaccines Market Share by Type: 2025 & 2032
Figure 4. Preventive Medicine Product Picture
Figure 5. Medicine Product Picture
Figure 6. Global Self-replicating mRNA Vaccines Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Self-replicating mRNA Vaccines Market Share by Application: 2025 & 2032
Figure 8. Infectious Disease
Figure 9. Cancer
Figure 10. Others
Figure 11. Global Self-replicating mRNA Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Self-replicating mRNA Vaccines Market Size (US$ Million), 2021–2032
Figure 13. Global Self-replicating mRNA Vaccines Sales (K Units), 2021–2032
Figure 14. Global Self-replicating mRNA Vaccines Average Price (US$/Unit), 2021–2032
Figure 15. Self-replicating mRNA Vaccines Report Years Considered
Figure 16. Self-replicating mRNA Vaccines Sales Share by Manufacturers in 2025
Figure 17. Global Self-replicating mRNA Vaccines Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Self-replicating mRNA Vaccines Players: Market Share by Revenue in Self-replicating mRNA Vaccines in 2025
Figure 19. Self-replicating mRNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Self-replicating mRNA Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Self-replicating mRNA Vaccines Sales Market Share by Country (2021–2032)
Figure 22. North America Self-replicating mRNA Vaccines Revenue Market Share by Country (2021–2032)
Figure 23. United States Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Self-replicating mRNA Vaccines Sales Market Share by Country (2021–2032)
Figure 26. Europe Self-replicating mRNA Vaccines Revenue Market Share by Country (2021–2032)
Figure 27. Germany Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Self-replicating mRNA Vaccines Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Self-replicating mRNA Vaccines Revenue Market Share by Region (2021–2032)
Figure 34. China Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Self-replicating mRNA Vaccines Sales Market Share by Country (2021–2032)
Figure 42. Latin America Self-replicating mRNA Vaccines Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Self-replicating mRNA Vaccines Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Self-replicating mRNA Vaccines Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Self-replicating mRNA Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Self-replicating mRNA Vaccines by Type (2021–2032)
Figure 53. Global Revenue Market Share of Self-replicating mRNA Vaccines by Type (2021–2032)
Figure 54. Global Self-replicating mRNA Vaccines Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Self-replicating mRNA Vaccines by Application (2021–2032)
Figure 56. Global Revenue Market Share of Self-replicating mRNA Vaccines by Application (2021–2032)
Figure 57. Global Self-replicating mRNA Vaccines Price (US$/Unit) by Application (2021–2032)
Figure 58. Self-replicating mRNA Vaccines Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
